OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
60
Results
Show all
Save search
Copy query
Show results for
Unknown
(59)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Orbitrap Exploris 480
(1)
Publication Date
2023
(1)
Release Date
2022
(10)
2025
(9)
2021
(9)
2024
(7)
2015
(5)
2023
(4)
2016
(3)
2020
(2)
2014
(2)
2013
(2)
2009
(2)
2019
(1)
2017
(1)
2012
(1)
2011
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
PRM and DDA Data for IR5 WIW and WIW Nanobodies
Journal Article: Structure-based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils
ORGANISM(S):
Synthetic Antibodies
Nanobodies
2023-06-16
|
MSV000092197
|
MassIVE
Cite
A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.
Not available
S-EPMC9063851
|
biostudies-literature
Cite
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Not available
S-EPMC4857599
|
biostudies-literature
Cite
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Not available
S-EPMC7333177
|
biostudies-literature
Cite
SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution.
Not available
S-EPMC8831033
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis.
Not available
S-EPMC12751851
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.
Not available
S-EPMC9404618
|
biostudies-literature
Cite
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets